ENO1 Knockdown Impedes Tumour Progression and Promotes Oxidative Phosphorylation in Cutaneous Squamous Cell Carcinoma
Acta Dermato-Venereologica · 2025
DOI: 10.2340/actadv.v105.43849 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Dermato-Venereologica, 2025. Verfasst von Liumei Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China; Department of Pathology, The First Affiliated Ho…. Hauptthemen laut MEDLINE: Skin Neoplasms, Carcinoma, Squamous Cell, Phosphopyruvate Hydratase, Tumor Suppressor Proteins. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Cutaneous squamous cell carcinoma (cSCC) is a common skin malignancy characterized by aggressive growth and metabolic reprogramming. Alpha-enolase (ENO1), a key glycolytic enzyme that is frequently over-expressed in cancer, has not been thoroughly investigated in cSCC, particularly with regard to how it coordinates glycolysis and oxidative phosphorylation (OXPHOS). ENO1 expression was interrogated in Gene Expression Omnibus datasets and validated in cSCC patient specimens. ENO1 was silenced in cSCC cell lines, and the resulting effects on cell viability, migration, invasion, apoptosis, and reactive oxygen species (ROS) levels were quantified. The impact of ENO1 knockdown on tumour growth was assessed in a xenograft model. Metabolic flux was analysed with Seahorse XFe96 extracellular-flux assays. ENO1 was significantly elevated in cSCC relative to normal skin and correlated positively with proliferative and invasive markers, but negatively with apoptosis markers. ENO1 silencing curtailed cell viability, migration, and invasion, while inducing apoptosis. Additionally, tumour growth was significantly impaired in vivo. Seahorse analysis showed that ENO1 knockdown suppressed glycolysis and redirected metabolic flux toward OXPHOS. Consistent with this shift, intracellular ROS increased and partially suppressed cell viability by modulating the ROS-sensitive Akt/mTOR pathway. In conclusion, ENO1 knockdown compromises tumorigenicity and promotes OXPHOS. Combining ENO1 inhibition with oxidative-stress-enhancing treatments, such as chemotherapy or radiotherapy, may further enhance efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China; Department of Pathology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Endocrinology, Shaanxi Provincial People's Hospital, Xi'an, China.
- Department of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Dermatology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
- Department of Dermatology, Xi'an People's Hospital, Xi'an, China.
- Department of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. zenyan66@126.com.
Zitieren
APA
Song, L., Ma, S., Wang, S., Zhang, X., Fan, W., Wang, N., Feng, S., Duan, Q., Bai, R., & Zheng, Y. (2025). ENO1 Knockdown Impedes Tumour Progression and Promotes Oxidative Phosphorylation in Cutaneous Squamous Cell Carcinoma. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v105.43849
Vancouver
Song L, Ma S, Wang S, Zhang X, Fan W, Wang N, et al. ENO1 Knockdown Impedes Tumour Progression and Promotes Oxidative Phosphorylation in Cutaneous Squamous Cell Carcinoma. Acta Dermato-Venereologica. 2025. doi:10.2340/actadv.v105.43849
BibTeX
@article{Song2025,
author = {Song, Liumei and Ma, Sharui and Wang, Shengbang and Zhang, Xiu and Fan, Wenxin and Wang, Ning and Feng, Shuo and Duan, Qiqi and Bai, Ruimin and Zheng, Yan},
title = {ENO1 Knockdown Impedes Tumour Progression and Promotes Oxidative Phosphorylation in Cutaneous Squamous Cell Carcinoma},
journal = {Acta Dermato-Venereologica},
year = {2025},
doi = {10.2340/actadv.v105.43849}
}
EUVIMED